ciprofloxacin has been researched along with biochanin a in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barreca, ML; Cannalire, R; Cecchetti, V; Couto, I; Felicetti, T; Machado, D; Manfroni, G; Massari, S; Sabatini, S; Santos Costa, S; Tabarrini, O; Viveiros, M | 1 |
| Guo, N; Li, L; Li, ZH; Liang, JC; Liu, G; Liu, LH; Liu, MY; Shen, FG; Wang, W; Wang, XL; Wu, XP; Xing, MX; Yu, L | 1 |
| Ding, H; Jin, H; Kong, Y; Qi, C; Ruan, Z; Xie, X; Zhang, J; Zou, Y | 1 |
3 other study(ies) available for ciprofloxacin and biochanin a
| Article | Year |
|---|---|
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
Topics: Anti-Bacterial Agents; Drug Design; Genistein; Mycobacterium avium; Quinolones | 2017 |
In Vitro Synergy of Biochanin A and Ciprofloxacin against Clinical Isolates of Staphylococcus aureus.
Topics: Ciprofloxacin; Genistein; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Spectrophotometry; Staphylococcus aureus | 2011 |
Biochanin A partially restores the activity of ofloxacin and ciprofloxacin against topoisomerase IV mutation-associated fluoroquinolone-resistant Ureaplasma species.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Genistein; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Phytoalexins; Sesquiterpenes; Ureaplasma | 2017 |